The activities and strategic direction for the Working Group are guided by a constituency-based Core Group, which represents the major stakeholder groups involved in TB vaccine R&D. The Secretariat is housed at Aeras.

The current Core Group includes:

Secretariat: Jonathan Daniels (USA)